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Oral squamous cell carcinoma is part of head and neck squamous cell carcinoma which is the ultimate cause of morbidity 
and mortality in cancer. The alteration of microbial community in the saliva might act as a helpful marker for the prediction, 
detection and prognosis oral cancer, particularly the transition of cancer precursor lesion. There are three mechanisms 
of action of oral microbiota in cancer pathogenesis, chronic inflammation of bacterial stimulation, carcinogenesis by 
cytoskeletal rearrangements, and carcinogenic substances that produced by microorganisms. Changes in the composition 
of microbiota could therefore have the potential to be used as a significant oral biomarker to predict the pathological 
transition from oral epithelial precursor lesion to cancer.
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Oral squamous cell carcinoma (OSCC), a part of head 
and neck squamous cell carcinoma (HNSCC), has a high 
recurrence rate with lymph node.1 Most of the OSCC cases 
were diagnosed at late stage, hence the risk of secondary 
primary tumors was higher.2-5 The 2019 death rate of oral 
and pharyngeal cancers was 10,860 cases in the United 
States of America, and tongue cancer was the main cause 
of death in oral cancer.6 Recently, the rates of oral cancers 
have increased in developed countries such as Japan with an 
estimated of 7,000 new cases and 3,000 deaths with the 2:1 
male-to-female ratio.7 The 5-year cancer survival rate was 
60-80%, but with early detection, the survival rate will rise
to 90%.6,7 Meanwhile in Indonesia in 2014, 319 oral cancer
cases were diagnosed over the past 15 years at Dharmais
National Cancer Hospital.8 The Dharmais data showed that
OSCC was most frequently found on the tongue, nearly
70% were advanced stage with bad prognosis and poor
survival rates.8
Tobacco, betel quid, and alcohol are the primary risk 
factors for OSCC.1 About 74% of OSCC cases are caused 
by tobacco chewing with or without betel nut. Risk factors 
such as tobacco smoking, alcohol consumption, and poor 
oral hygiene can inevitably make the case worse.2 Not 
only chemical irritants such as cigarette and alcohol, but 
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the dental prosthesis inflammation, human papillomavirus 
(HPV), and chronic periodontitis infection can also increase 
the risk of oral cancer.1 
Chronic periodontal disease involves a pathological 
organism that will increase the risk of premalignant lesions 
and cancer.6 According to some studies, oral pre-cancers 
and cancers affect the composition of the oral microbiome. 
In vice versa, chronic inflammation of bacterial infection 
induces cell proliferation, mutagenesis, oncogene activation 
and angiogenesis as well.3 Helicobacter pylori is the first 
bacterium known as carcinogenic inducer.4 Additionally, 
Porphyromonas gingivalis is another pathogenic bacterium 
that frequently found in OSCC. OSCC patients mostly 
suffer from chronic periodontitis, resulting in chronic 
inflammatory OSCC cells.5 The relation between oral 
cancer-inducing factors and bacterial ecology is significant 
since alterations in oral microbiome have also been found 
in subjects consuming alcohol, betel quid and smoking.9 
Besides P. gingivalis, OSCC is strongly associated with 
bacteria such as Streptococcus sp., Peptostreptococcus 
sp., Prevotella sp., and Capnocytophaga gingivalis, while 
Fusobacterium, Veillonella, Actinomyces, Clostridium, 
Haemophilus and Enterobacteriaceae are associated with 
precursor lesions of the epithelium.3 
Oral Microbiome in Healthy Individuals 
Actinomyces, Capnocytophaga, Eikenella, Eubacteria, 
Fusobacterium, Haemophilus, Lactobacterium, 
Leptotrichia, Neisseria, Porphyromonas, Prevotella, 
Propionibacterium, Peptostreptococcus, Streptococcus, 
Staphylococcus, Veillonella and Treponema exist in 
healthy people's oral cavity. Other than that, Firmicutes, 
Proteobacteria, Actinobacteria, Bacteroidetes and 
Fusobacteria are also prevalent oral microbial species in 
healthy individuals.10 Those commensal species live with 
the host immune defense systems in equilibrium.9 The host-
microbiota co-dependence is preserved with host-provided 
nutrient-rich environment, while the commensal microbes 
secrete nutrient processing metabolites, avoid pathogenic 
microbe infections, and maintain homeostasis by stimulating 
immune responses.10 Streptococcus is the predominant oral 
microbiome healthy genus.4 Commensal and pathogenic 
bacterial organisms, by forming biofilm, circumvent the 
host immune response. Any disturbances of this equilibrium 
and reorganization of the microbial composition have 
been involved in various diseases such as, dental caries or 
periodontal diseases.9 Most of these microorganisms live in 
a symbiotic capacity in our oral cavity, establishing mutually 
beneficial relationships with the host. Not only they are not 
harmful, but these commensal populations can also keep 
pathogenic organisms under control by not allowing them 
to adhere to mucosal surfaces.11 
Commensal bacteria with proper inhibitors may 
improve the effectiveness of immunotherapy.5 Compared 
with programmed death ligand 1 (PD-L1) specific antibody 
therapy, Bifidobacterium by oral administration controlled 
tumor growth with the same efficacy. Both the oral 
administration of Bifidobacterium and the PD-L1-specific 
antibody avoided tumor outgrowth. Bifidobacterium 
oral administration improves antitumor resistance and 
changes the effectiveness of control-point inhibitors as an 
immunotherapeutic agent by modifying the composition of 
intestinal microorganisms.12 
Oral Microbiome in Cancer Patients 
Oral microbial communities tend to vary from stable sites to 
malignant sites. For example, Streptococcus anginosus and 
Treponema denticola associate with multiple carcinomas 
of the upper gastrointestinal tract.13 In general, anginosal 
infection may be involved in the carcinogenesis of 
HNSCC. The DNA of S. anginosus was found in specimens 
of carcinoma tissue but not in samples of lymphoma, 
rhabdomyosarcoma, or leukoplakia. Dental plaque may act 
as a dominant reservoir of this bacterium.14,15
 In the pre-cancerous oral lesions, leukoplakia, 
Bacteroidetes and Fusobacteria are substantially enriched, 
compared to normal contralateral tissue in the same 
patients.4,16 Meanwhile among patients with oral cancer, 
a substantial increase in the number of C. gingivalis, 
P. melaninogenica,  and  S. mitis  among  patients  was
reported.17
The incidence of cancer worldwide also refers to 
virus-related infections such as hepatitis viruses, HPV, and 
Epstein-Barr virus (EBV).4 Nonetheless, in order to put 
viral infections in perspective, it has been estimated that 
at least six human viruses, EBV, hepatitis B virus (HBV), 
hepatitis C virus (HCV), HPV, human T-cell lymphotropic 
virus (HTLV-1) and Kaposi's associated sarcoma virus 
(KSHV)  lead to 10-15% of all cancers worldwide.18,19 HPV 
has been  known  recently as an etiological factor that cause 
oropharyngeal cancer, however, infection which caused by 
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HPV  is  not  a  main  contributor  to  oral  cancer,  since  the 
virus is infrequently found in oral cancers (only 2–4% of 
cases).20 
Pathogenesis of Oral Microorganisms in 
Cancer Development
There are three mechanisms of oral microbiota in 
carcinogenesis. The first is the chronic inflammation 
bacterial stimulation. Such mechanism may results 
inflammatory mediators that may promote cells proliferation, 
angiogenesis activation and mutagenesis. With regard to the 
second mechanism, bacteria can influence carcinogenesis 
by cytoskeletal rearrangements, activation of nuclear factor-
kappaB (NF-kB), and cellular apoptosis inhibition. The 
third mechanism is carcinogenic substances that produced 
by microorganisms.21
Stimulation of Chronic Inflammation
Porphyromonas, Prevotella and Fusobacterium as 
anaerobic species in oral cavity have significant role for 
periodontal diseases and chronic inflammatory mechanism. 
These bacteria induce inflammatory mediators production 
which affect epithelial and endothelial cells, fibroblasts, and 
extracellular matrix. These periodontal pathogens may affect 
the body to produce various cytokines such as interleukin 
(IL)‐1β, IL‐6, IL‐17, IL‐23, tumor necrosis factor (TNF)‐α, 
and matrix metalloproteinases (MMP)‐8 and MMP‐9.22
 In response to lipopolysaccharide (LPS), the key 
element of Gram-negative bacteria walls, the neutrophils, 
fibroblasts, and mast cells in periodontium tissues 
may synthesize IL‐1β (Figure 1). The IL‐1β induces 
the development of osteoclasts and bone resorption23, 
resulting in alterations of sectional inflammatory in the 
periodontium. IL‐1β also provokes the secretion of acute 
phase proteins, prostaglandins (PG), phospholipase A2, 
and proinflammatory cytokines such as TNF‐α, IL‐6, and 
MMPs.5,24 Furthermore, IL‐1β also encourages endothelial 
cells to produce Vascular Endothelial Growth Factor 
(VEGF) and many proangiogenic factors.25 IL‐1β was 
also associated with lower E‐cadherin expression, which 
promotes cell migration.26 Therefore, high level of IL‐1β 
is associated to proliferation, more invasive and aggressive 
phenotype of a tumor.25,27 
 IL‐6, which produced by the influence of LPS, 
IL‐1β and TNF‐α, also causes bone resorption and 
enhances the synthesis of PGE2, acute phase proteins, and 
chemokines.1,28-32 IL‐6 generates oxidative stress and may 
lead to a short-term aggregation of H2O2 in mitochondria, 
resulting in damage of mitochondrial.33 IL‐6 also affects 
the invasion and metastasis process by promoting MMPs 
expressions. Furthermore, IL‐6 increases the release of 
Intercellular Adhesion Molecules (ICAMs) and Endothelial 
Leukocyte Adhesion Molecules (ELAMs), that promote 
adhesion of endothelial cells to tumor cells, thereby 
influencing the spread of tumors. Most genes activated by 
IL‐6 are involved in the progression of the cell cycle and 
apoptosis suppression. IL‐6 may influence the development 
of cancer by affecting anti-apoptotic pathways as well.5,31,34 
 TNF‐α is secreted due to various elements, including 
bacterial LPS. Furthermore, TNF‐α highly induces the 
progression of reactive oxygen species (ROS), PG, 
leukotrienes, and MMPs. TNF‐α also decreases the 
production of osteogenic cells and fibroblasts. Unlike high 
doses of TNF‐α that associated with tumor destruction, 
tumor development is related to low doses of TNF‐α.35,36 
TNF-α induces tumor growth by activation of carcinogenic 
signaling pathways in epithelial cells, including Wnt and 
NF‐kB.28 TNF‐α also has the ability of generating ROS to 
cause DNA damage. It has been shown that TNF‐α affects 
motility and invasion processes by inducing MMPs to 
express and induce the development of various angiogenic 
factors such as IL‐8 and VEGF.37 
Anti-apoptotic Mechanisms
Epithelial cell responses to infection of P. gingivalis in both 
apoptosis and cell division. P. gingivalis can highly induce 
anti-apoptotic activity in primary cultures of gingival 
epithelial cells.14 Role of P. gingivalis infection in tumor 
development remains to be determined, however, there 
is a solid proof of its inherent ability to influence many 
aspects of epithelial cell signaling. P. gingivalis promotes 
intracellular signaling of Jak1/Akt/Stat3, which lead to 
inhibition of mitochondrial apoptosis pathway6, which 
has been targeted for inducing apoptosis in oral cancer 
cell.38,39 It demonstrated the ability to lower the activity of 
p53 tumor suppressor.40 P. gingivalis induces significant 
phosphorylation and inhibition of Bad in the membrane of 
mitochondrial  as well as  enhancing  Bcl2/Bax ratios. In 
addition, P. gingivalis also suppresses caspases, important 
apoptotic machinery proteins which has been targeted for 
inducing apoptosis in oral cancer cell as well.39 
 P. gingivalis may also triggered adhesion of purinergic 
receptor P2X7-ATP, which plays a significant role in 
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Figure 1. The mechanisms of chronic inflammation in carcinogenesis. Various inflammatory mediators induced by 
LPS bacteria may promote angiogenesis and tumor progression, aggressive tumor phenotype, invasion and metastasis, 
mitochondrial damage and adhesions of tumor cells. 
in mitochondria NF-κB
E-cadherin
neovascularization, metastasis, cell growth and secretion of 
inflammatory cytokines. This microorganism has shown its 
capability to release an anti-apoptotic enzyme nucleoside 
diphosphate kinase (NDK) that cleaves ATP and inhibits the 
activation of proapoptotic P2X7 receptor (Figure 2), thus 
facilitating the signaling of ATP/P2X7.5  This NDK secretion 
may also regulate the cytosolic ATP-induced and ROS 
of mitochondrial which is an important mediator for the 
activation of transcription elements related to inflammation 
and the development of cancer.5,41 In addition, P. gingivalis 
produces gingipains, which actually are cysteine proteinases, 
that can break the MMP‐9 pro-enzyme into its mature 
active form.5,21,40 Gingipains activation of MMP‐9 induces 
degradation of the structure of the basal membrane, which 
encourages migration and invasion of cancer cells.5,42
 Another oral microorganism, Fusobacterium 
nucleatum, may be the causative agent of oral squamous 
cell, pancreatic, and colorectal cancers.  F. nucleatum 
infection modulates many anti-apoptotic pathways43, 
including Toll-like receptor (TLR) activation and NF‐
kB signaling (Figure 3).41 The most important part in the 
direct role of F. nucleatum in the carcinogenesis is the 
adhesin/invasin FadA, which adheres to E‐cadherin on 
cancer cells and encourages the signaling of β‐catenin. 
This pathway leads to increase Wnt transcriptional activity, 
pro-inflammatory cytokine activation, oncogenes, and 
cancer cells proliferation stimulation.5,44 F. nucleatum also 
stimulates p38, leads to secretion of MMP-9 and MMP-13. 
Similar to MMP-9, MMP-13 also plays a significant  role in 
tumor metastasis and invasion.42 
Carcinogenic Effect Substances
Microorganisms play an important role in the 
metabolization of alcohol to acetaldehyde.5 Many types of 
oral microorganisms including streptococci S. Gordonii, 
S. Mitis, S. oralis, S. Salivary, S. sanguinis, and Candida 
yeasts, have the alcohol dehydrogenase (ADH) enzyme, 
that metabolizes alcohol to acetaldehyde with subsequent 
potential for oral cancer growth.45 
 Lactic acid is produced by certain oral bacteria of 
the genus Lactococcus, Lactobacillus, Streptococcus, 
Bifidobacterium, Leuconostoc and Pediococcus. 
Some species can produce more acids, for example 
Peptostreptococcus stomatis which produces acetic, 
butyric, isobutyric, isovaleric and isocaproic acids.5 The 
majorities of bacteria isolated from the OSCC tissues were 
 56
Role of Oral Microbiology in Oral CancerHayati N, et al.
Figure 2. P. gingivalis can cause cell-cycle changes and apoptosis inhibition. Extracellular P. gingivalis may induce 
inflamation and promote cancell cell invasion and migration through gingipains proteinases. Intracellular P. gingivalis may 
inhibit apoptosis mechanism and disrupt cell cycle through activation of Jak1 and decrease the activity of p53.
saccharolytic and aciduric bacteria.46 Such microorganisms 
may influence the pH reduction in the local environment by 
generating lactic acid. This acid production may enhance 
the acidic and hypoxic tumor microenvironment, thus 
increasing metastatic capability.47 
 Several oral microorganisms such as P. 
gingivalis, Prevotella intermedia, Aggregatibacter 
actinomycetemcomitans, and F. nucleatum contain volatile 
sulfur compounds (VSC), such as hydrogen sulfide (H2S), 
dimethyl sulfide ((CH3)2S), dimethyl disulfide (CH3SSCH3) 
and methyl mercaptan (CH3SH).5 H2S appears in saliva at 
the highest concentration, while CH3SH is the dominant 
compound in the gingival pockets. H2S is known as 
genotoxic agent and may result in cumulative mutations 
or genomic instability. Increased expression of various 
H2S-producing enzymes in cancer cells has been observed, 
particularly in colon and ovarian cancers.48
 It was also shown that H2S promotes apoptosis in 
human gingival epithelial cells through mitochondrial 
pathway activation (Figure 4).49 Upon cell exposure to H2S, 
apoptosis was remarkably increased at 24 and 48 hours, 
ROS was enhanced, and depolarization of the mitochondrial 
membrane was disintegrated. Release of Cytochrome C, a 
small protein known to be related with the mitochondrial 
inner membrane involved in apoptosis initiation, increased 
significantly. Activities of Caspase-9 and -3 were reported 
highly stimulated, while the activity of caspase-8 remained 
low. In 48-hours the percentage of DNA-strand-break 
increased.48,49 
 Recent findings suggest that there are various 
mechanisms that lead to the effect of H2S on cancer, 
consist of angiogenesis induction, control of mitochondrial 
bioenergetics, cell cycle progression acceleration, and 
anti-apoptosis functions.50 Studies showed that H2S has 
proangiogenic effects by enhancing the expression of VEGF 
in both kidney and ischemic tissues.51 In addition, many 
evidence suggests that H2S is an endogenous angiogenesis 
stimulator and promotes the growth and proliferation of 
tumor cells. Cystathionine β-synthase (CBS)-derived H2S is 
used to induce angiogenesis and vasorelaxation, therefore 
promoting tumor growth in colon cancer.50,52
 Growing evidence suggests that H2S is involved in 
regulating mitochondrial function and cellular bioenergetics 
by direct donation of electrons and mitochondrial 
phosphodiesterases inhibition.50 CBS co-locates with 
mitochondrial markers in ovarian cancer cells, and 
silencing CBS reduces the intake of mitochondrial oxygen 
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summary, CBS that generated from H2S could sustain 
cellular bioenergetics in cancer cells, therefore promoting 
tumor growth and proliferation.50 However, a recent study 
also shows that exogenous H2S (NaHS, 200-500 μM) might 
serve as a proliferative induced factor that accelerates the 
progression of the cell cycle in oral squamous cell carcinoma 
by increasing phosphorylation of protein kinase B (PKB)/ 
Akt and extracellular signal-regulated kinase (ERK).50,54
Microbiology Alteration as Biomarker for Oral Diagnostic
There are more than 500 species microorganisms in saliva 
of oral cancer patients, both cultivated and uncultivated 
varieties.3 Compared to the approximately 50 strains 
observed using standard experimental methods, this 
large data set reflects significant improvement. Changes 
in the microbial community (Peptostreptococcus, 
Bacillus, Parvimonas, Enterococcus, and Slackia) in the 
saliva could act as a convenient marker for predicting, 
and detecting oral cancer, particularly the epithelial 
precursor lesion-cancer transition. At least nine bacteria, 
including Alistipes, Bacteroids, Blautia, Clostridium, 
Dorea, Escherichia, Faecalibacterium, Megamonas, and 
Phascolarctobacterium, showed positive associations in the 
epithelial precursor lesion and cancer groups. In addition, 
the normal group detected a very different positive/negative 
correlation network, suggesting community alteration in the 
disease group. Such associations may indicate the microbial 
community changes in saliva, which could identify many 
combinations of microorganisms associated with oral cancer 
and epithelial precursor lesions.3 High salivary numbers of 
Capnocytophaga gingivalis, Prevotella melaninogenica 
and Streptococcus mitis can be used as OSCC diagnostic 
indicators. The involvement of on the salivary microbiota 
on OSCC has more severe effect than tobacco.17 The 
surfaces of OSCC display significantly elevated levels of 
Porphyromonas and Fusobacterium relative to healthy 
mucosa.55,56 
Conclusion
There are three mechanisms of action of oral microbiota 
in cancer pathogenesis, chronic inflammation of 
bacterial stimulation, carcinogenesis by cytoskeletal 
rearrangements, and carcinogenic substances that produced 
by microorganisms. The alteration of microbial community 
in the saliva might represent as a convenient marker for 
Figure 3. F. nucleatum can generate an oncogenic phenotype of epithelial cell. FadA will activating pathway of β-catenin, 
which leads to cell survival and proliferation. Intracellular F. nucleatum through p38 may cause MMP-9 and MMP-13 
activation, which play an important part in cell invasion.
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the prediction, detection, and prognosis of oral cancer, 
especially the epithelial precursor lesion-cancer transition.
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Figure 4. A schematic ilustration of H2S in developing cancer cell proliferation. Induction of angiogenesis, regulation of 
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form of nicotinamide adenine dinucleotide; ATP: adenosine 5'-triphosphate; ROS: reactive oxygen species;  Bax: B-cell 
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